Seeing Is Believing
Currently out of the existing stock ratings of Young Li, 7 are a BUY (41.18%), 10 are a HOLD (58.82%).
Analyst Young Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 38.1% that have a potential upside of 13.56% achieved within 43 days. Previously, Young Li worked at UBS.
Young Li’s has documented 36 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on STAA, STAAR Surgical Company at 22-Sep-2026.
Analyst best performing recommendations are on CNMD (CONMED).
The best stock recommendation documented was for CNMD (CONMED) at 10/11/2022. The price target of $85 was fulfilled within 31 days with a profit of $10.04 (13.39%) receiving and performance score of 4.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$1.9 (9.95%)
$16
2 months 4 days ago
(30-Jul-2026)
2/2 (100%)
$2.93 (16.21%)
134
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
7 months 7 days ago
(27-Feb-2026)
14/22 (63.64%)
$2.64 (18.38%)
129
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
2 years 4 months 5 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 09-Aug-2023
$32
$12.9 (67.54%)
3 years 1 months 25 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$15.9 (83.25%)
$55
4 years 6 months 25 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
Which stock is Young Li most bullish on?
Which stock is Young Li most reserved on?
What Year was the first public recommendation made by Young Li?